Alpine Immune and AbbVie sign $865m immunology deal
Clinical-stage immunotherapy firm Alpine Immune Sciences and biopharmaceutical company AbbVie have signed an option and license agreement potentially worth $805m,…
Latest Autoimmune disorder
-
4 months
-
5 months
-
8 months
-
8 months
-
4 months
-
5 months
-
8 months
-
8 months
UK access to PrEP ‘indefinitely postponed’ due to Covid-19
PrEP is a daily tablet – sold by Gilead under the brand names Truvada and Descovy, with generics expected to…
Latest News
View More
Alpine Immune and AbbVie sign $865m immunology deal
Clinical-stage immunotherapy firm Alpine Immune Sciences and biopharmaceutical company AbbVie have signed an option and license agreement potentially worth $805m, for ALPN-101 drug. ALPN-101, a…
Takeda’s SC Entyvio meets primary endpoint in Crohn’s Disease
At the European Crohn’s and Colitis Organization (ECCO) congress in Vienna, Austria, Takeda announced the subcutaneous (SC) formulation of Entyvio (vedolizumab) met its primary endpoint…
Terns to commercialise GENFIT’s elafibranor to treat NASH and PBC
Terns Pharmaceuticals has signed an agreement to acquire the exclusive rights to develop, register and market GENFIT’s elafibranor. The drug…
Janssen’s Tremfya shows promise in two Phase III psoriatic arthritis trials
Johnson & Johnson subsidiary Janssen has announced that Tremfya (guselkumab) reached its primary endpoint in the Phase III DISCOVER one…
Company A-Z
View More
SIRION Biotech
Customised Viral Vectors for Cell Modelling, Gene Therapy, and Vaccination Research and Development
Cytiva (formerly GE Life Sciences)
Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines
Latest Content
View More
Metabolic disorders on Twitter: Diabetes leads mentions in August 2019
Pharmaceutical Technology lists the top tweeted terms on metabolic disorders in August 2019, based in data from Global Data’s Influencer…
EC expands label of Janssen’s Stelara to include ulcerative colitis
Johnson & Johnson subsidiary Janssen has announced the European Commission (EC) has approved Stelara (ustekinumab) for patients with moderately to…
Softigel by Procaps Announces New Website Launch
Softigel by Procaps, a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the pharmaceutical and…
Six Steps to Handle High-Potent Molecules in a Shared Facility
In recent years, the development of highly potent molecules has become more frequent, and around 25% of the components that…
Samsung Biologics’ P4 Super Plant, Songdo
Samsung Biologics is planning to expand its manufacturing facilities with the construction of its fourth biopharmaceutical manufacturing plant, P4-Super Plant,…
Micronova Bags and Liners for Containment Functions in Cleanroom Areas
Bio/pharma, compounding pharmacies and other life science industries are continually attempting to minimise material contamination. As a result, The need…